Monthly Archives: December 2010
Fixing Biotech's Broken Business Model
Despite some notable successes, the global biotech industry has fallen short of expectations. Strategic collaborations have been on the increase, but there is now a need for more co-operation using new collaboration models, writes Jo Pisani.
The current business model on which biotech has relied is flawed. Due to poor rates of
return, investment has dried [...]
Posted in Biotech, Deals, Emerging Markets, Europe, Global, Guest Blog, R&D Tagged biopharmaceuticals, Biotechnology, China, emergin g markets, finance, Global, healthcare, india, payers Leave a comment
New PwC Paper Looks Ahead into the Future of Pharma
Continuing cost pressures and new customer demands require a fresh look at existing roles of industry players.
A new paper from PwC, entitled “Top Health Industry Issues of 2011,” foretells of change in the coming year due to health reform and other issues that are keeping the industry on its toes.
“The new health reform law will [...]
Looking Into the Future: FDA’s 2011 Guidance Agenda
On December 7, FDA released its annual guidance agenda, which serves as a blueprint—almost a wish list— for what the organization plans to focus its time and resources on in the coming year.
FDA’s good guidance practices regulations [GGP] require it to publish for public comment an annual summary of key priorities in the coming calendar [...]
Federal Judge Declares Mandatory Health Insurance Unconstitutional
This new decision out of Virginia increases the prospect of a showdown between an elected Congress and President and the Supreme Court over the legality of this year’s health reform legislation affecting nearly one-fifth of the US economy. Resolution of the court case is unlikely before 2012—which is also an election year.
Earlier this week, [...]

Global Health Spotlight Turns to Chronic Disease